Cohort 0 6 0 6 O
1 7 8 7 8 O
: 8 9 8 9 O
HIV-1 10 15 10 15 B-chronic_disease
infected 16 24 16 24 O
adolescents 25 36 25 36 O
( 37 38 37 38 O
12 38 40 38 40 B-lower_bound
to 41 43 41 43 O
< 44 45 44 45 O
18 46 48 46 48 B-upper_bound
years 49 54 49 54 I-upper_bound
of 55 57 55 57 O
age 58 61 58 61 B-age
and 62 65 62 65 O
screening 66 75 66 75 B-clinical_variable
weight 76 82 76 82 I-clinical_variable
≥ 83 84 83 84 O
35 85 87 85 87 B-lower_bound
kg 88 90 88 90 I-lower_bound
) 90 91 90 91 O
who 92 95 92 95 O
are 96 99 96 99 O
virologically 100 113 100 113 O
suppressed 114 124 114 124 O
for 125 128 125 128 O
≥ 129 130 129 130 O
6 131 132 131 132 B-lower_bound
months 133 139 133 139 I-lower_bound
prior 140 145 140 145 I-lower_bound
to 146 148 146 148 O
screening 149 158 149 158 O

Cohort 0 6 159 165 O
2 7 8 166 167 O
: 8 9 167 168 O
HIV-1 10 15 169 174 B-chronic_disease
infected 16 24 175 183 O
children 25 33 184 192 O
( 34 35 193 194 O
6 35 36 194 195 B-lower_bound
to 37 39 196 198 O
< 40 41 199 200 O
12 42 44 201 203 B-upper_bound
years 45 50 204 209 I-upper_bound
of 51 53 210 212 O
age 54 57 213 216 B-age
and 58 61 217 220 O
screening 62 71 221 230 O
weight 72 78 231 237 B-clinical_variable
≥ 79 80 238 239 O
25 81 83 240 242 B-lower_bound
kg 84 86 243 245 I-lower_bound
) 86 87 245 246 O
who 88 91 247 250 O
are 92 95 251 254 O
virologically 96 109 255 268 O
suppressed 110 120 269 279 O
for 121 124 280 283 O
≥ 125 126 284 285 O
6 127 128 286 287 B-lower_bound
months 129 135 288 294 I-lower_bound
prior 136 141 295 300 I-lower_bound
to 142 144 301 303 O
screening 145 154 304 313 O

Cohort 0 6 314 320 O
3 7 8 321 322 O
: 8 9 322 323 O
HIV-1 10 15 324 329 B-chronic_disease
infected 16 24 330 338 O
children 25 33 339 347 O
( 34 35 348 349 O
≥ 35 36 349 350 O
2 37 38 351 352 B-lower_bound
years 39 44 353 358 I-lower_bound
of 45 47 359 361 O
age 48 51 362 365 B-age
and 52 55 366 369 O
screening 56 65 370 379 B-clinical_variable
weight 66 72 380 386 I-clinical_variable
of 73 75 387 389 O
≥ 76 77 390 391 O
14 78 80 392 394 B-lower_bound
to 81 83 395 397 O
< 84 85 398 399 O
25 86 88 400 402 B-upper_bound
kg 89 91 403 405 I-upper_bound
) 91 92 405 406 O
who 93 96 407 410 O
are 97 100 411 414 O
virologically 101 114 415 428 B-clinical_variable
suppressed 115 125 429 439 I-clinical_variable
for 126 129 440 443 O
≥ 130 131 444 445 O
6 132 133 446 447 B-lower_bound
months 134 140 448 454 I-lower_bound
prior 141 146 455 460 I-lower_bound
to 147 149 461 463 O
screening 150 159 464 473 O

Estimated 0 9 474 483 O
glomerular 10 20 484 494 B-clinical_variable
filtration 21 31 495 505 I-clinical_variable
rate 32 36 506 510 I-clinical_variable
( 37 38 511 512 I-clinical_variable
GFR 38 41 512 515 I-clinical_variable
) 41 42 515 516 I-clinical_variable
≥ 43 44 517 518 O
90 45 47 519 521 B-lower_bound
mL 48 50 522 524 I-lower_bound
/ 50 51 524 525 I-lower_bound
min/1.73 51 59 525 533 I-lower_bound
m^2 60 63 534 537 I-lower_bound
according 64 73 538 547 O
to 74 76 548 550 O
the 77 80 551 554 O
Schwartz 81 89 555 563 O
Formula 90 97 564 571 O

Individuals 0 11 572 583 O
undergoing 12 22 584 594 O
dose 23 27 595 599 O
modifications 28 41 600 613 O
to 42 44 614 616 O
their 45 50 617 622 O
antiretroviral 51 65 623 637 B-treatment
regimen 66 73 638 645 I-treatment
for 74 77 646 649 O
growth 78 84 650 656 O
or 85 87 657 659 O
who 88 91 660 663 O
are 92 95 664 667 O
switching 96 105 668 677 O
medication 106 116 678 688 O
formulation(s 117 130 689 702 O
) 130 131 702 703 O
are 132 135 704 707 O
considered 136 146 708 718 O
to 147 149 719 721 O
be 150 152 722 724 O
on 153 155 725 727 O
a 156 157 728 729 O
stable 158 164 730 736 O
antiretroviral 165 179 737 751 O
regimen 180 187 752 759 O

No 0 2 760 762 O
documented 3 13 763 773 O
or 14 16 774 776 O
suspected 17 26 777 786 O
resistance 27 37 787 797 O
to 38 40 798 800 O
emtricitabine 41 54 801 814 B-treatment
( 55 56 815 816 I-treatment
FTC 56 59 816 819 I-treatment
) 59 60 819 820 I-treatment
, 60 61 820 821 O
tenofovir 62 71 822 831 B-treatment
( 72 73 832 833 I-treatment
TFV 73 76 833 836 I-treatment
) 76 77 836 837 I-treatment
, 77 78 837 838 O
or 79 81 839 841 O
integrase 82 91 842 851 B-treatment
strand 92 98 852 858 I-treatment
transfer 99 107 859 867 I-treatment
inhibitors 108 118 868 878 I-treatment
( 119 120 879 880 I-treatment
INSTIs 120 126 880 886 I-treatment
) 126 127 886 887 I-treatment
including 128 137 888 897 O
, 137 138 897 898 O
but 139 142 899 902 O
not 143 146 903 906 O
limited 147 154 907 914 O
to 155 157 915 917 O
, 157 158 917 918 O
the 159 162 919 922 O
reverse 163 170 923 930 O
transcriptase 171 184 931 944 O
resistance 185 195 945 955 O
mutations 196 205 956 965 O
K65R 206 210 966 970 O
and 211 214 971 974 O
M184V 215 220 975 980 O
/ 220 221 980 981 O
I 221 222 981 982 O

Stable 0 6 983 989 B-treatment
antiretroviral 7 21 990 1004 I-treatment
regimen 22 29 1005 1012 I-treatment
of 30 32 1013 1015 I-treatment
2 33 34 1016 1017 I-treatment
nucleoside 35 45 1018 1028 I-treatment
reverse 46 53 1029 1036 I-treatment
transcriptase 54 67 1037 1050 I-treatment
inhibitors 68 78 1051 1061 I-treatment
( 79 80 1062 1063 I-treatment
NRTIs 80 85 1063 1068 I-treatment
) 85 86 1068 1069 I-treatment
in 87 89 1070 1072 I-treatment
combination 90 101 1073 1084 I-treatment
with 102 106 1085 1089 I-treatment
a 107 108 1090 1091 I-treatment
third 109 114 1092 1097 I-treatment
agent 115 120 1098 1103 I-treatment
for 121 124 1104 1107 O
a 125 126 1108 1109 O
minimum 127 134 1110 1117 O
of 135 137 1118 1120 O
6 138 139 1121 1122 B-lower_bound
months 140 146 1123 1129 I-lower_bound
prior 147 152 1130 1135 I-lower_bound
to 153 155 1136 1138 O
the 156 159 1139 1142 O
screening 160 169 1143 1152 O
visit 170 175 1153 1158 O

Unconfirmed 0 11 1159 1170 B-clinical_variable
virologic 12 21 1171 1180 I-clinical_variable
elevations 22 32 1181 1191 I-clinical_variable
of 33 35 1192 1194 O
≥ 36 37 1195 1196 O
50 38 40 1197 1199 B-lower_bound
copies 41 47 1200 1206 I-lower_bound
/ 47 48 1206 1207 I-lower_bound
mL 48 50 1207 1209 I-lower_bound
( 51 52 1210 1211 O
transient 52 61 1211 1220 B-chronic_disease
detectable 62 72 1221 1231 I-chronic_disease
viremia 73 80 1232 1239 I-chronic_disease
, 80 81 1239 1240 O
or 82 84 1241 1243 O
blip 85 89 1244 1248 B-chronic_disease
) 89 90 1248 1249 O
prior 91 96 1250 1255 O
to 97 99 1256 1258 O
screening 100 109 1259 1268 O
are 110 113 1269 1272 O
acceptable 114 124 1273 1283 O

